Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026

SBC vs ZGM: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

SBC Captures Overall Composite Edge (47.2 HOLD vs 59.4 HOLD), While ZGM Leads 3–2 on Growth & Valuation Pillars

SBC Overall Winner 6-Pillar Tally: SBC 2 – 3 ZGM (1 Tie) Matrix Metrics: SBC 7 – 3 ZGM

As of Nov 20, 2026, SBC Medical Group Holdings Incorporated (SBC) captures the overall head-to-head institutional edge over Zenta Group Company Limited (ZGM) on higher Unified Composite conviction (47.2/100 HOLD vs. 59.4/100 HOLD) after splitting the core matrix 7–3 (led by Valuation Multiples, Growth & Scale), while ZGM wins 3–2 across the 6-pillar growth and valuation breakdown. SBC trades at $5.17 (9.0x Forward P/E, 39.9% operating margin) versus ZGM at $1.65 (N/M Forward P/E, 31.7% operating margin).

  • Composite vs. Pillar Nuance: While ZGM currently prints a higher short-term Unified Composite Score (59.4/100 HOLD vs. SBC 47.2/100 HOLD), SBC captures the overall institutional head-to-head verdict (7–3 matrix metrics and 2–3 across the 6 pillars) due to superior fundamental profitability (39.9% vs. 31.7% operating margin) and revenue trajectory (+35.1% vs. -27.0% YoY).

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About SBC vs ZGM
SBC NASDAQ Head-to-Head Winner
SBC Medical Group Holdings Incorporated Common Stock
Services-Offices & Clinics Of Doctors Of Medicine
$5.17
-7.68% 1D
Market Cap $574.4M
TTM Revenue $190M
Forward P/E 9.0x
Beta / 30D Vol 0.96β · 159% Vol
Unified Composite Score
47.2 / 100 HOLD
Tech 41.0 Fund 36.0 Flow 50.0 Mom 50.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 46
RSI-14: 46.2 · SMA20: $5.54 · SMA50: $5.28
ZGM NASDAQ
Zenta Group Company Limited Ordinary Shares
Services-Management Consulting Services
$1.65
+7.14% 1D
Market Cap $18.2M
TTM Revenue $3.2M
Forward P/E N/M
Beta / 30D Vol 0.88β · 161% Vol
Unified Composite Score
59.4 / 100 HOLD
Tech 60.0 Fund 54.0 Flow 50.0 Mom 50.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 52
RSI-14: 51.6 · SMA20: $1.52 · SMA50: $1.81

6-Pillar Scorecard Institutional Category Breakdown (SBC 2 – 3 ZGM)

Columns: Metric · SBC · ZGM
1. Valuation Multiples SBC
Forward P/E 9.0x N/M
Trailing P/E 11.0x 15.4x
PEG Ratio 2.40x N/M
EV / Revenue 3.0x 5.7x
2. Growth & Scale SBC
Revenue Growth (YoY) +35.1% -27.0%
Earnings Growth (YoY) +22.4% -78.0%
TTM Revenue (USD) $190M $3.2M
Market Cap $574.4M $18.2M
3. Profitability & Quality ZGM
Gross Margin 72.2% 78.1%
Operating Margin 39.9% 31.7%
Net Profit Margin 27.3% 31.7%
Return on Equity (ROE) 19.3% 23.4%
4. Balance Sheet & Cash Flow ZGM
Cash Generation (TTM) $80M EBITDA $1.3M EBITDA
Cash Flow Margin 41.8% EBITDA Mgn 42.7% EBITDA Mgn
Net Cash / Leverage $2.79 Book/Sh · 19.3% ROE $0.59 Book/Sh · 23.4% ROE
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning Tie
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile N/A (N/A) N/A (N/A)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Neutral NEUTRAL · Neutral
6. R&D & Supply-Chain Moat ZGM
OpEx & R&D Intensity 32.3% of Rev ($61M) 46.4% of Rev ($1.5M)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat High-Margin Pricing Power Moat High-Margin Pricing Power Moat
Supply-Chain Role Consulting Services Operator Consulting Services Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: SBC (7) vs ZGM (3)
Institutional Metric SBC ZGM Criterion Row Edge
Market Capitalization
Scale
$574.4M $18.2M Larger Scale SBC
Trailing P/E Ratio
Valuation
11.0x 15.4x Lower Multiple SBC
Forward P/E Ratio
Valuation
9.0x N/M Lower Multiple SBC
Revenue Growth (YoY)
Growth
+35.1% -27.0% Higher Growth SBC
Operating Margin (TTM)
Profitability
39.9% 31.7% Higher Margin SBC
Net Profit Margin
Profitability
27.3% 31.7% Higher Margin ZGM
Return on Equity (ROE)
Capital Efficiency
19.3% 23.4% Higher ROE ZGM
52-Week Range Position
Momentum
52% ($3–$7) 16% ($1–$5) Stronger Trend SBC
Beta / 30D Volatility
Risk Regime
0.96β · 159% Vol 0.88β · 161% Vol Lower Realized Risk SBC
Unified Institutional Score
Composite Signal
47.2 / 100 (HOLD) 59.4 / 100 (HOLD) Higher Composite ZGM
Trailing 12M Revenue (USD)
Operating Scale
$190M $3.2M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
72.2% 78.1% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
2.40x PEG · 3.0x EV/Rev N/M PEG · 5.7x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
$80M EBITDA ($2.79 Book/Sh · 19.3% ROE) $1.3M EBITDA ($0.59 Book/Sh · 23.4% ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon SBC +32.62 pp
SBC: +21.81% · ZGM: -10.81%
3M Horizon SBC +31.89 pp
SBC: -3.15% · ZGM: -35.04%
6M Horizon SBC +59.69 pp
SBC: +36.08% · ZGM: -23.61%
1Y Horizon SBC +59.69 pp
SBC: +36.08% · ZGM: -23.61%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on SBC vs ZGM. Trailing 12-month operating profitability (SBC 39.9% vs ZGM 31.7%) and valuation multiples (SBC 9.0x vs ZGM N/M Forward P/E) are benchmarked directly in Pillar 4 below.

SBC ADR TTM Benchmark FX-Normalized USD
TTM Revenue$190M
Gross Margin72.2%
Op. Margin39.9%
ROE / Fwd P/E19.3% · 9.0x
ZGM ADR TTM Benchmark FX-Normalized USD
TTM Revenue$3.2M
Gross Margin78.1%
Op. Margin31.7%
ROE / Fwd P/E23.4% · N/M

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
SBC UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact SBC Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
ZGM UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact ZGM Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
SBC Moat Profile High-Margin Pricing Power Moat
Consulting Services Operator
Competes within the Consulting Services value chain with $574.4M market capitalization and 39.9% operating margin.
OpEx & R&D Reinvestment 32.3% of Rev ($61M)
90D Engineering Disclosures 0 Published
ZGM Moat Profile High-Margin Pricing Power Moat
Consulting Services Operator
Competes within the Consulting Services value chain with $18.2M market capitalization and 31.7% operating margin.
OpEx & R&D Reinvestment 46.4% of Rev ($1.5M)
90D Engineering Disclosures 0 Published

Investor FAQ SBC vs ZGM Key Questions & Quantitative Answers

As of Nov 20, 2026, SBC Medical Group Holdings Incorporated (SBC) captures the overall head-to-head institutional edge over Zenta Group Company Limited (ZGM) on higher Unified Composite conviction (47.2/100 HOLD vs. 59.4/100 HOLD) after splitting the core matrix 7–3 (led by Valuation Multiples, Growth & Scale), while ZGM wins 3–2 across the 6-pillar growth and valuation breakdown. SBC trades at $5.17 (9.0x Forward P/E, 39.9% operating margin) versus ZGM at $1.65 (N/M Forward P/E, 31.7% operating margin). Composite vs. Pillar Nuance: While ZGM currently prints a higher short-term Unified Composite Score (59.4/100 HOLD vs. SBC 47.2/100 HOLD), SBC captures the overall institutional head-to-head verdict (7–3 matrix metrics and 2–3 across the 6 pillars) due to superior fundamental profitability (39.9% vs. 31.7% operating margin) and revenue trajectory (+35.1% vs. -27.0% YoY).

SBC leads the Growth & Scale pillar: SBC posts +35.1% YoY revenue growth and +22.4% YoY earnings growth on $190M TTM revenue (72.2% gross margin, 39.9% operating margin), compared with ZGM at -27.0% YoY revenue growth and -78.0% YoY earnings growth on $3.2M TTM revenue (78.1% gross margin, 31.7% operating margin). On trailing 12-month operating scale, SBC generates $190M in USD-normalized revenue versus $3.2M for ZGM. In operating R&D and SG&A reinvestment, SBC deploys 32.3% of Rev ($61M) (0 90-day corporate R&D disclosures) versus 46.4% of Rev ($1.5M) (0 disclosures) for ZGM.

SBC screens cheaper on headline valuation multiples. SBC trades at 9.0x Forward P/E, 11.0x Trailing P/E, 2.40x PEG, and 3.0x EV/Revenue (41.8% EBITDA margin), whereas ZGM trades at N/M Forward P/E, 15.4x Trailing P/E, N/M PEG, and 5.7x EV/Revenue (42.7% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against SBC (19.3% ROE) versus ZGM (23.4% ROE) capital efficiency.

In options market volatility and institutional positioning, SBC carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.96β · 159% Vol realized risk). By comparison, ZGM carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.88β · 161% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.